Stock Movers: Sunrun, Hims & Hers, and Williams-Sonoma Discussed

Sunrun's Solar Setback

• ☀️ Sunrun shares experienced a significant drop, down as much as 42% at one point, marking its largest ever intraday decline.
• 📉 This downturn is attributed to a new House Republican tax and spending bill that aims to end clean electricity production incentives earlier than planned, potentially starting in 2022.
• ⚠️ The bill's requirement for projects to begin construction within 60 days of enactment could disincentivize investment in the solar and renewable energy sectors.

Hims & Hers Faces Competition

• 💊 Hims & Hers shares slumped, down 5% from an earlier low of 11%, following Cigna's announcement.
• 💰 Cigna's drug benefit unit will cap out-of-pocket costs for weight-loss drugs at $200 per month, offering a cheaper alternative to the telehealth platform's compounded versions of branded drugs.
• 💡 This move by Cigna could impact Hims & Hers, as insurance typically does not cover compounded obesity drugs, making the capped out-of-pocket cost attractive to consumers.

Williams-Sonoma's Cautious Outlook

• 🏠 Williams-Sonoma shares fell 8% despite reporting results above expectations and reaffirming full-year net revenue guidance.
• 📊 The company's net revenue was $1.73 billion, up 4.2% year-over-year, with a projected revenue range of -1.5% to 1.5%.
• 🧐 Analysts expressed disappointment over the lack of a guidance bump, especially given the strong quarterly performance, with some suggesting the quarter benefited from pre-tariff purchases.